Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Search results for:

inclisiran

inclisiran
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Leqvio INJECTION, SUBCUTANEOUS 189 mg/mL      
Comments:

Restricted to use by cardiology in the outpatient setting, including in-office administration. Each case will be evaluated for reimbursement or specialty pharmacy benefits prior to being scheduled to receive the drug.

Reviewed: July 2022 (Leqvio)

Last updated: Jul. 28, 2022






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved